A-101 Assessing Glycemic Control in Potential Blood Donor at the Blood Bank of the University College Hospital, Ibadan, Nigeria

Abstract

Abstract Background Voluntary blood donation exercise remains one the safest means of sourcing for blood product made available for patients. However, there are several eligibility criteria put in place before a prospective donor can be accepted for donation exercise. One of the eligibility criteria not commonly considered is the glycemic control of a donor. This is because pooly controlled diabetes being treated with insulin or a patent with type 1 Dm is considered unfit for blood donation. This study carried out was to determine gycemic control of the prospective donors by assaying their HBA1C levels before blood donation at the blood bank of the university college hospital, Ibadan, Nigeria. Methods Venous blood of the prospective donors was collected during the screening exercise that precedes blood donation to determine eligibility. The blood was for the assay of HBA1C was collected into EDTA bottle and analysed using spectrophometric method. A total number of 184 prospective donors were screened within a period of three weeks. Any result that falls between 4.0%–5.6% was considered normal, 5.7%–6.4% was considered Pre-diabetic while results that are greater than 6.5% were considered diabetic and likely not fit for blood donation. Results A total number of 184 apparently healthy young adult between the ages of 19 and 45 years were screened. Out of the 184 prospective donors, 42 (22.8%) of the population were female, the remaining 142 (77.2%) were male. I56 (84.7%) of the population screened had normal gycemic control between 4.0%–5.6% while 20 (15.2%) of the population had a pre-diabetic results (5.7%–6.4%). The reaming 2 (1.1%) prospective donors had poor glycemic control (>6.5%). This suggests that most of the donors had good glycemic control. Conclusion As much as a good attention is placed on other eligibility criteria for blood donation attention should also be placed on the glycemic control of donor for the safety of both the donor and the recipients of blood products.